Skip to main content
OpenTrials
Active, Not Recruiting

NCT Number: NCT01727284

MR-Guided Cryoablation of Prostate Bed Recurrences

The purpose of this research is to see if MR-guided cryoablation can effectively treat prostate tumor recurrences.

Active, Not Recruiting

This study is active but is not currently recruiting participants.

Notify Me

Key information

Age range

30 year–100 year

Sex eligibility

Male

Study type

Interventional

Phase

Not applicable

Primary location

Mayo Clinic in Rochester

Rochester, Minnesota, 55905, United States

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Patients with "biopsy proven" soft tissue tumor recurrences of prostate fossa
  • Surgery is not a desirable alternative therapy at the time of enrollment
  • Radiation therapy has failed or not indicated or can be safely postponed
  • Tumor size is < 5 cm at its largest diameter
  • Tumor does not encompass the rectal wall or external urethral sphincter
  • Patient is able to undergo MRI

Exclusion criteria

  • N/A

Treatment and study plan

MR-guided cryoablation

Procedure

Primary outcomes

  1. Evaluation of target lesion at 3-6, 12, 24, and 36 month imaging follow-up

    Time frame: 3 years

Sponsors and collaborators

Lead sponsor

Mayo Clinic

Other

Registry information

Official study title

Technical Success, Safety, and Short and Long-term Efficacy for MR-Guided Cryoablation of Prostate Bed Recurrences

Important dates

Study start
2012
Primary completion
2026
Study completion
2026
First posted
Nov 15, 2012
Registry last updated
Sep 4, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.